Insiders Were Right: DBD Makes New 52-Week High

In trading on Wednesday, shares of Diebold, Inc. ( DBD) touched a new 52-week high of $35.96/share. That's a 30.34% rise, or $8.37 per share from the 52-week low of $27.59 set back on 03/06/2013. That means at today's intraday high, any investor who purchased DBD stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, DBD has seen 4 different instances of insiders buying over the trailing six month period.

Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
08/30/2013 Andreas W. Mattes President and CEO 1,000 $28.50 $28,500.00
09/09/2013 John D. Kristoff VP, Chief Communications Ofcr. 200 $29.16 $5,831.98
12/06/2013 Andreas W. Mattes President and CEO 500 $32.88 $16,438.10
12/11/2013 Sheila M. Rutt VP, Chief HR Officer 150 $31.85 $4,776.90
12/11/2013 Stefan Merz Sr. VP, Strategic Projects 300 $32.07 $9,622.26
12/11/2013 John D. Kristoff VP, Chief Communications Ofcr. 100 $31.67 $3,167.00

The chart below shows where DBD has traded over the past year, with the 50-day and 200-day moving averages included.

If you liked this article you might like

Diebold Is Getting Hammered After 'Haunting' Guidance -- Jim Cramer Breaks It All Down

Bullish and Bearish Reversals for This Week

Jim Cramer's Top Takeaways: IBM, Diebold Nixdorf, Digital Realty Trust

Jim Cramer's 'Mad Money' Recap: Don't Miss This Rotation Back Into the Nasdaq

7 Breakout Stocks Spiking on Big Volume